Searched for
DAIICHI SANKYO COMPANY
NCLAT quashes Ligare Aviation's insolvency; loan from Religare Enterprises round-tripping of moneyThe National Company Law Appellate Tribunal has cancelled insolvency proceedings against Ligare Aviation. The tribunal found the National C...- After 50 hearings, court reserves judgement in Daiichi-Fortis caseThe Delhi High Court has reserved its judgment in a significant arbitration case. Japanese drug maker Daiichi Sankyo is seeking to enforce ...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Tokyo Court to rule on Fortis arm IHH and Daiichi Sankyo disputeA significant legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. The Tokyo District Court will announce its jud...
- IHH-Daiichi legal battle nears verdict on September 10A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...
- Despite litigation, IHH says it is focused on key milestones for FortisMalaysia-based hospital operator IHH Healthcare has reached out to its largest shareholder Mitsui & Co. to help open communication with Jap...
- Daiichi comments continue to damage interests: IHH UnitNorthern TK Venture, a subsidiary of IHH Healthcare, has increased its legal claim against Daiichi Sankyo. The claim is now for ₹11,800 cro...
- Ranbaxy, Daiichi Sankyo to leverage synergies in ThailandRanbaxy Laboratories and its Japanese parent Daiichi Sankyo to integrate their business operations in Thailand to maximise synergies.
- Daiichi Sankyo reports Q3 net loss of $255 millionDaiichi Sankyo suffered a net loss of $255 million in the Octr-Dec quarter of 2011 due to a strong yen and one-time charges related to Ranb...
- Ranbaxy to sell Daiichi Sankyo product in MalaysiaDrug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo today said Ranbaxy will market its parent company's products in Malaysia.
- Ranbaxy, Daiichi Sankyo to expand business in MexicoThe two cos will launch Daiichi Sankyo's Olmesartan Medoxomil, used to treat high blood pressure, in Mexico before end of 2011.
- Daiichi to use Ranbaxy network to sell products in SingaporeRanbaxy and Daiichi Sankyo had signed a three-year plan to exploit synergies in operations to enhance their generic as well as branded busi...
- Ranbaxy transfers new drug discovery unit to Daiichi SankyoRanbaxy Laboratories on Friday said it has transferred its new drug discovery research unit (NDDR) to Daiichi Sankyo India Pharma.
- Daiichi sets up firm to market Ranbaxy products in JapanRanbaxy’s Japanese parent Daiichi Sankyo has set up a new firm, Daiichi Sankyo Espha Company (DSECL) for marketing generic drugs in Japan.
- FIPB rejects Zenotech plea against DaiichiThe country’s foreign investment regulator has rejected a plea by Zenotech Laboratories seeking the withdrawal of its earlier ruling that a...
- Daiichi to meet US FDA to resolve Ranbaxy issueDaiichi Sankyo, the Japanese pharmaceutical company that bought Ranbaxy Laboratories last year, will meet US FDA officials next month to so...
- Daiichi to meet FDA, launches 1st drug through RanbaxyDaiichi Sankyo, the new owner of Ranbaxy Laboratories will meet US Food and Drugs Administration (FDA) officials next month to sort out the...
- Daiichi sees $3.9 bn loss on Ranbaxy buyJapan's Daiichi Sankyo, the new owner of India's largest drugmaker Ranbaxy Laboratories expects a non-cash valuation loss of $3.9 billion o...
- Daiichi acquires 20% from Ranbaxy promoters, hikes stake to over 50%Ranbaxy is now a subsidiary of Japanese drug major Daiichi Sankyo.
- Japan's Daiichi to set up manufacturing, research unitThe $8-billion Daiichi Sankyo Company, Japan’s second-largest pharma company, is in the process of setting up a full-fledged manufacturing ...
Load More
